Neuland Laboratories Limited (NSE:NEULANDLAB)

Neuland Laboratories Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 24, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	164,489	80,588	23,087	13,171	26,788	3,637
Market Cap Growth	159.63%	249.07%	75.28%	-50.83%	636.62%	-57.97%
Enterprise Value	163,681	80,232	24,941	15,076	28,580	5,175
Last Close Price	12784.00	6311.23	1794.74	1019.53	2066.54	279.41
PE Ratio	54.85	26.86	14.12	20.64	33.22	22.43
PS Ratio	10.73	5.17	1.94	1.38	2.86	0.48
PB Ratio	11.79	6.28	2.32	1.57	3.41	0.51
P/TBV Ratio	14.77	8.05	3.24	2.36	5.32	0.85
P/FCF Ratio	-	68.58	13.49	-	31.90	42.56
P/OCF Ratio	-	30.86	9.73	21.81	14.15	6.34
EV/Sales Ratio	10.67	5.15	2.09	1.58	3.05	0.68
EV/EBITDA Ratio	43.28	17.49	8.93	10.74	19.72	5.06
EV/EBIT Ratio	52.05	19.89	10.82	15.69	26.07	7.03
EV/FCF Ratio	-	68.28	14.58	-	34.04	60.57
Debt / Equity Ratio	0.08	0.07	0.13	0.29	0.23	0.37
Debt / EBITDA Ratio	0.29	0.21	0.46	1.67	1.23	2.54
Debt / FCF Ratio	-	0.81	0.75	-	2.17	30.87
Asset Turnover	-	0.91	0.80	0.70	0.73	0.65
Inventory Turnover	-	2.33	2.26	2.16	2.38	2.32
Quick Ratio	-	1.10	0.95	0.69	0.63	0.61
Current Ratio	-	2.15	1.73	1.60	1.49	1.44
Return on Equity (ROE)	-	26.36%	17.83%	7.85%	10.78%	2.30%
Return on Assets (ROA)	-	14.77%	9.73%	4.44%	5.36%	3.90%
Return on Capital (ROIC)	14.35%	20.16%	13.08%	5.86%	7.05%	4.83%
Return on Capital Employed (ROCE)	-	28.70%	20.20%	9.40%	11.50%	8.40%
Earnings Yield	1.82%	3.72%	7.08%	4.85%	3.01%	4.46%
FCF Yield	-	1.46%	7.41%	-2.83%	3.13%	2.35%
Dividend Yield	0.11%	0.22%	0.56%	0.49%	0.24%	0.72%
Payout Ratio	-	4.28%	3.92%	6.03%	3.18%	30.53%
Buyback Yield / Dilution	-0.01%	-	-	-	-	-1.93%
Total Shareholder Return	0.10%	0.22%	0.56%	0.49%	0.24%	-1.22%

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.